A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours
NCT05717348
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Locally Advanced Solid Tumor
Metastatic Solid Tumor
Interventions
DRUG:
ES014
Sponsor
Elpiscience (Suzhou) Biopharma, Ltd.